COMP <GO>
RYN vs HR // RETURN ON INVESTED CAPITAL (ROIC)
Rayonier Inc. (NYSE) VS. Healthcare Realty Trust Incorporated (NYSE) • 15-METRIC TALLY: RYN 5
— HR 6
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: RYN
LAST: $19.62 (-2.73%) • MKT CAP: $6.00B
roic
3.00%
LAST: $19.18 (+0.31%) • MKT CAP: $6.47B
roic
-3.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RYN VS. HR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RYN | HR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 3.00% | -3.70% | +6.70 | RYN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 56.0x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.12% | 7.34% | -3.22 | HR | /fcf-yield <GO> |
| Operating Margin | 17.30% | -60.00% | +77.30 | RYN | /operating-margins <GO> |
| Net Profit Margin | 68.00% | -60.00% | +128.00 | RYN | /net-margins <GO> |
| Revenue Growth (YoY) | -51.00% | 47.30% | -98.30 | HR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.13% | 6.23% | -1.10 | HR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | HR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 64.4 | 65.7 | -1.30 | HR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.09 | 1.02 | +0.07 | RYN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.2x | 34.0x | -22.80 | RYN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.00B | $6.47B | -$471.0M | HR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RYN REV | HR REV | RYN GROSS % | HR GROSS % | RYN FCF | HR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $483.0M | $28.2M | 32.3% | — | $234.9M | $455.8M |
| FY 2024 | $986.4M | $19.2M | 44.5% | — | $217.2M | $500.8M |
| FY 2023 | $787.0M | $17.5M | — | — | $263.0M | $499.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RYN // BETA 1.09
HR // BETA 1.02